Back

Clinical experience with aficamten from the US

30 August 2026 (15:41 - 15:51)
Organised by: Logo
Congress Presentation Part of: Advancements in treatment for oHCM and clinical practice experiences with aficamten Hypertrophic Cardiomyopathy Open Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Martin Maron

Lahey Hospital & Medical Centre, Burlington (United States of America)

3 More presentations in this session

Presentation thumbnail
The evolving landscape of oHCM and aficamten in the clinical setting
Doctor A. Pantazis (London, GB)
Video
Presentation thumbnail
Practical experience and considerations with aficamten in Europe
Professor I. Eitel (Luebeck, DE)
Video
Presentation thumbnail
Advancements in treatment for oHCM and clinical practice experiences with aficamten - Key takeaways and discussion
Video

Access the full session

Session thumbnail
Advancements in treatment for oHCM and clinical practice experiences with aficamten
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 15:41 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of long-term treatment with aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy: results from FOREST-HCM
31 August 2025
thumbnail
Congress Presentation
Real-world symptom and echocardiographic improvement in obstructive HCM patients treated with mavacamten: evidence of favorable disease modification
1 September 2025
thumbnail
Congress Presentation
Spotlight on cardiac myosin inhibition
1 September 2024
thumbnail
Congress Presentation
Safety and Outcomes of Standard of Care Medications Withdrawal in Patients with Obstructive Hypertrophic Cardiomyopathy Treated with Aficamten in FOREST-HCM Trial
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources